CONMED Corporation CNMD
NYSE
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -2.31% | 8.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.31% | 8.34% | |||
| Cost of Revenue | 11.34% | 4.14% | |||
| Gross Profit | -11.60% | 11.40% | |||
| SG&A Expenses | -4.23% | 3.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.41% | 3.45% | |||
| Operating Income | -35.68% | 49.51% | |||
| Income Before Tax | -17.03% | 70.78% | |||
| Income Tax Expenses | -24.93% | 82.81% | |||
| Earnings from Continuing Operations | -14.20% | 66.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -14.20% | 66.84% | |||
| EBIT | -35.68% | 49.51% | |||
| EBITDA | -25.68% | 32.14% | |||
| EPS Basic | -13.79% | 69.72% | |||
| Normalized Basic EPS | -52.87% | 73.15% | |||
| EPS Diluted | -13.98% | 70.51% | |||
| Normalized Diluted EPS | -53.12% | 73.03% | |||
| Average Basic Shares Outstanding | -0.48% | -1.70% | |||
| Average Diluted Shares Outstanding | 0.03% | -1.65% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||